Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.7050
+0.0350 (2.10%)
NASDAQ· Last Trade: Jun 4th, 11:17 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors